The first batch of German-made Pfizer-BioNTech COVID-19 vaccine arrived in mainland China on April 13 and was made available to Chinese people for vaccination with a fee.
This is the first time that the Chinese regime allowed Chinese people to receive an imported COVID-19 vaccine.